MenPF-1 - A New Vaccine Against Meningococcal Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

May 6, 2022

Conditions
Serogroup B Meningococcal Disease
Interventions
BIOLOGICAL

MenPF-1.

A new vaccine against meningococcal disease.

Trial Locations (1)

OX3 7LE

Centre for Clinical Vaccinology & Tropical Medicine (CCVTM), Oxford

All Listed Sponsors
collaborator

Wellcome Trust

OTHER

collaborator

Norwegian Institute of Public Health

OTHER_GOV

lead

University of Oxford

OTHER

NCT01640652 - MenPF-1 - A New Vaccine Against Meningococcal Disease | Biotech Hunter | Biotech Hunter